Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

The Medicines Company Company Profile (NASDAQ:MDCO)

Consensus Ratings for The Medicines Company (NASDAQ:MDCO) (?)
Ratings Breakdown: 6 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $30.17 (38.06% upside)

Current Analysts' Coverage Summary for The Medicines Company (NASDAQ:MDCO)
Show:
DateFirmActionRatingPrice TargetDetailsShare
10/10/2014Credit SuisseReiterated RatingNeutral$28.00 -> $26.00ViewTweet This Rating  Share This Rating on StockTwits
8/21/2014ZacksReiterated RatingNeutral -> Neutral$28.00ViewTweet This Rating  Share This Rating on StockTwits
4/17/2014Leerink SwannDowngradeOutperform -> Market Perform$30.00 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
4/2/2014Piper JaffrayDowngradeOverweight -> Neutral$41.00 -> $29.00ViewTweet This Rating  Share This Rating on StockTwits
3/31/2014TheStreetDowngradeBuy -> HoldViewTweet This Rating  Share This Rating on StockTwits
2/13/2014RBC CapitalLower Price TargetOutperform$50.00 -> $44.00ViewTweet This Rating  Share This Rating on StockTwits
2/13/2014Jefferies GroupDowngradeBuy -> Hold$38.50 -> $27.00ViewTweet This Rating  Share This Rating on StockTwits
8/15/2013Bank of AmericaUpgradeNeutral -> Buy$36.00 -> $40.00ViewTweet This Rating  Share This Rating on StockTwits
6/20/2013OppenheimerInitiated CoverageOutperform -> Market PerformViewTweet This Rating  Share This Rating on StockTwits
3/27/2013GuggenheimInitiated CoverageMarket Perform -> Buy$39.00ViewTweet This Rating  Share This Rating on StockTwits
2/21/2013WallachBeth CapitalBoost Price TargetBuy$30.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013ISI GroupInitiated CoverageBuy$30.00ViewTweet This Rating  Share This Rating on StockTwits
12/20/2012JPMorgan Chase & Co.UpgradeNeutral -> Overweight$28.00 -> $28.00ViewTweet This Rating  Share This Rating on StockTwits
10/25/2012Citigroup Inc.Initiated CoverageNeutral$27.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 10/23/2012 forward)
Discuss The Medicines Company